Cargando…
GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals
BACKGROUND: Glucagon-like peptide-1 (GLP-1) treatment has been shown to reduce stroke incidence in diabetes and also to be neuroprotective in experimental stroke models. The prognostic value of endogenous levels of GLP-1 in the recovery phase after stroke remains to be elucidated. The aim of the stu...
Autores principales: | Larsson, Martin, Patrone, Cesare, von Euler, Mia, Holst, Jens J., Nathanson, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628501/ https://www.ncbi.nlm.nih.gov/pubmed/31307484 http://dx.doi.org/10.1186/s12933-019-0896-z |
Ejemplares similares
-
Sex, Diastolic Blood Pressure, and Outcome after Thrombolysis for Ischemic Stroke
por: Nathanson, David, et al.
Publicado: (2014) -
The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
por: Darsalia, Vladimer, et al.
Publicado: (2018) -
GLP-1 secretion by microglial cells and decreased CNS expression in obesity
por: Kappe, Camilla, et al.
Publicado: (2012) -
Safety of thrombolysis in stroke mimics: an observational cohort study from an urban teaching hospital in Sweden
por: Kostulas, Nikolaos, et al.
Publicado: (2017) -
The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion
por: Hjørne, Anna Pii, et al.
Publicado: (2022)